Odyssean »

Vera Therapeutics shares owned by Odyssean

Quarter-by-quarter ownership of Vera Therapeutics (VERA) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Vera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vera Therapeutics held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vera Therapeutics by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.6M 60k 42.91

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Vera Therapeutics

venBio Select Advisor
BlackRock
T. Rowe Price Associates
Deep Track Capital
Deerfield Management Company
Kynam Capital Management
State Street Corporation
Sofinnova Ventures
Vanguard Capital Management
FMR
Eversept Partners
Bellevue Group
Integral Health Asset Management
Alliancebernstein
Geode Capital Management

View all funds holding Vera Therapeutics